Replies to post #108631 on Biotech Values

[mouton29]

<<They evidently didn’t see the irony in their remarks>>

Especially since Amphastar essentially won the battle, the FDA released the heparin, though it seems unlikely they will win the war (i.e., approval). Whereas SNY lost both the initial battle (the injunctiion they were seeking against the FDA was denied and, we expect, will lose the war.